CRISPR to Target Leukaemia
Researchers used CRISPR gene-editing to equip certain immune cells with a homing beacon to target leukaemia.
Gene Therapy
“Everyone Should Have Access to Affordable Gene Treatments”
At a biohacking conference this week, a biotech CEO dropped his pants and injected himself in the thigh with an experimental herpes treatment created by his company, leaving other biohackers worried.
2017: This Was Your Year
Now that the Festival of Genomics London is done, dusted, and in the record books, we take a look back at what you were busy reading on our website during 2017, including your answers from our survey.
CRISPR Tackles Deadly Disease That Stops The Heart From Beating
Scientists have tweaked the DNA in human heart cells to correct mutations that cause a deadly disease, which if proved safe could eventually cure children of Duchenne Muscular Dystrophy (DMD).
Stuff to Read, Week 5
This week we talk CRISPR delivery, precision medicine anno 2030, gene editing equality and three-person babies arriving in the UK.
Drugs Before and After Melanoma Surgery Improve Survival
A new approach to treatment for certain melanoma patients may lead to better results after surgery, a new study suggests.
High-Dose Gene Therapy More Harmful Than Previously Thought
A new animal study involving virally-delivered gene therapies has indicated that high treatment doses might not be as safe as previous human trials have suggested
Roche Wins FDA’s Breakthrough Therapy Label for Autism Drug
Drugmaker company, Roche has been granted FDA approval for its breakthrough therapy designation for Balovaptan to treat Autism Spectrum Disorder (ASD), potentially accelerating its development and approval.
Three Biotech’s Have Doubled Investors’ Money in Less Than a Year, But Who Are They?
Having a stock double in a year is pretty impressive, right? Writing for the Motley Fool, Keith Speights weighs in on three healthcare stocks that have done exactly that.
Should Self-Experimentation With Gene Editing Be Banned by the FDA?
Although very much disagreeing with biohacking practices, and strongly discouraging them, the FDA has never actually intervened themselves with individuals. Should they?
Drug Trio Aims at Two Cell Types in Pancreatic Cancer
A three-drug combination can simultaneously target pancreatic cancer cells, as well as the other harmful, inflammatory cells within tumours, according to new research.
Gene Therapy Could Make Cancer Care More Unequal – This is How
Two new cancer treatments have shown miraculous cures, but if you happen to live in a handful of rural states in the U.S. (let alone outside the U.S.) — you’ll have to travel hundreds of miles to get them. And it’s by no means certain that they’ll eventually be available everywhere.
New Gene Therapies Boost Drug Approvals
Growth in the development of rare disease medicines has helped boost the number of new drugs approved in both the United States and the European Union.
“My Greatest Achievement Has Been Overcoming My Own Shyness to Advocate My Disabled Child” – Judith Sheppard
Judith Sheppard is the parent of a 22-year-old young man with FOXG1 Syndrome. We’ve had a chat with her before her talk “Finding the Needle in the Haystack” at the Festival of Genomics in London 2018.
2020 is the New Hottest Date in Genomics
Year 2020 has been set as the delivery date for 500,000 whole exome sequences from the UK Biobank cohorts.
